The Dystonia Drug market is a subset of the Central Nervous System Drugs market. It is composed of drugs used to treat dystonia, a neurological disorder characterized by involuntary muscle contractions and spasms. These drugs are used to reduce the severity of symptoms, such as muscle spasms, cramps, and tremors. Commonly prescribed drugs include botulinum toxin, anticholinergics, and dopamine agonists. Other treatments, such as physical therapy, may also be used to manage dystonia. The Dystonia Drug market is highly competitive, with many companies offering products to treat the disorder. Some of the major players in the market include Allergan, Merz Pharmaceuticals, Teva Pharmaceuticals, AbbVie, and Ipsen. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
